We are live on
!
Find out more
ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
7.38%
This Fund
S&P 500
This Quarter
Est. Return
+11.21%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$255M
AUM Growth
–
Cap. Flow
+$243M
Cap. Flow
% of AUM
95.38%
Top 10 Holdings %
Top 10 Hldgs %
38.34%
Holding
87
New
87
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$14.7M |
| 2 |
Becton Dickinson
BDX
|
+$11.7M |
| 3 |
AGN
Allergan plc
AGN
|
+$9.93M |
| 4 |
Encompass Health
EHC
|
+$9.24M |
| 5 |
Elevance Health
ELV
|
+$9.04M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 85.71% |
| 2 | Technology | 1.03% |
| 3 | Financials | 0.67% |
| 4 | Consumer Staples | 0.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Illumina
ILMN
$31B
| $1.37M | 0.54% |
+7,652
| New | +$1.35M |
|
|
OCRX
52
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $1.34M | 0.53% |
+210,279
| New | +$1.23M |
|
53
Stryker
SYK
$125B
| $1.32M | 0.52% |
+13,994
| New | +$1.24M |
|
54
Teleflex
TFX
$6.05B
| $1.29M | 0.5% |
+11,200
| New | +$1.27M |
|
55
Vertex Pharmaceuticals
VRTX
$121B
| $1.28M | 0.5% |
+10,800
| New | +$1.22M |
|
|
WOOF
56
DELISTED
VCA Inc.
WOOF
| $1.28M | 0.5% |
+26,250
| New | +$1.18M |
|
57
Pfizer
PFE
$143B
| $1.26M | 0.49% |
+42,582
| New | +$1.22M |
|
58
Amphastar Pharmaceuticals
AMPH
$879M
| $1.24M | 0.49% |
+107,059
| New | +$1.17M |
|
59
Mettler-Toledo International
MTD
$28.6B
| $1.24M | 0.49% |
+4,100
| New | +$1.13M |
|
|
NSTG
60
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.19M | 0.47% |
+85,404
| New | +$1.04M |
|
61
Danaher
DHR
$137B
| $1.19M | 0.47% |
+20,606
| New | +$1.12M |
|
|
SSRG
62
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $1.12M | 0.44% |
+143,852
| New | +$1.09M |
|
63
Zimmer Biomet
ZBH
$18.2B
| $1.1M | 0.43% |
+9,991
| New | +$1.05M |
|
64
Abbott
ABT
$183B
| $1.07M | 0.42% |
+23,750
| New | +$1.03M |
|
|
KND
65
DELISTED
Kindred Healthcare
KND
| $1.07M | 0.42% |
+58,700
| New | +$1.16M |
|
|
PARN
66
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
| $1.03M | 0.41% |
+249,427
| New | +$1.13M |
|
67
Sanofi
SNY
$103B
| $967K | 0.38% |
+21,200
| New | +$1.03M |
|
|
AFFX
68
DELISTED
Affymetrix Inc
AFFX
| $961K | 0.38% |
+97,407
| New | +$851K |
|
69
Cencora
COR
$60.6B
| $929K | 0.36% |
+10,300
| New | +$883K |
|
|
SGMO
70
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $902K | 0.35% |
+59,300
| New | +$720K |
|
|
TRNX
71
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $864K | 0.34% |
+33,868
| New | +$863K |
|
|
ANAC
72
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $839K | 0.33% |
+26,000
| New | +$780K |
|
73
HCA Healthcare
HCA
$87.2B
| $780K | 0.31% |
+10,625
| New | +$747K |
|
74
QuidelOrtho
QDEL
$1.14B
| $633K | 0.25% |
+21,902
| New | +$594K |
|
75
Intuitive Surgical
ISRG
$127B
| $627K | 0.25% |
+10,665
| New | +$594K |
|
Similar funds
VAFP
CA
SCM
FWM
TOPU
CCMU
TGI
HSCU
Endurant Capital Management's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Endurant Capital Management, which disclosed 87 positions worth $255M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Thermo Fisher Scientific: 120,950 shares worth $15.2M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, followed by Technology and Financials.
- Endurant Capital Management's largest Q4 2014 buy was Thermo Fisher Scientific: 120,950 shares worth $15.2M.
- Endurant Capital Management's ten largest holdings make up 38% of its $255M portfolio in Q4 2014.
- Endurant Capital Management disclosed 87 positions in Q4 2014, its first 13F filing on record.
Based on Endurant Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.